Osteoporosis: Frequency, Consequences, and Risk Factors

doi:10.1001/archinte.1996.00440120051005

You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Vol. 156 No. 13, 8 JULY 1996

Online Only
	•	Online First Table of Contents

REVIEW ARTICLES

•	Online Features

This Article
•	References
•	Full text PDF
•	Reply to article
•	Send to a friend
•	Save in My Folder
•	Save to citation manager
•	Permissions

Citing Articles
•	Citation map
•	Citing articles on HighWire
•	Citing articles on Web of Science (144)
•	Contact me when this article is cited

Related Content
•	Similar articles in this journal

Social Bookmarking
	What's this?

Osteoporosis

Frequency, Consequences, and Risk Factors

Philip D. Ross, PhD

Arch Intern Med. 1996;156(13):1399-1411.

Abstract

More than half of all women and about one third of men willexperience osteoporotic fractures during their lives. Althoughno symptoms occur prior to fracture, bone mineral density andother risk factors can be used to identify high-risk patients,and because effective interventions exist, many of these fracturesare now preventable. The proportion of people who are affected,the mortality and morbidity resulting from osteoporotic fractures,and the major known risk factors are discussed. Greater attentionshould be given to measuring bone mineral density and identifyingother risk factors to quantitate the degree of fracture riskamong patients (with or without a history of previous fractures),because the consequences of fractures often are severe, andno symptoms other than fractures are associated with diseaseprogression.

Arch Intern Med. 1996;156:1399-1411

Author Affiliations

From the Hawaii Osteoporosis Center, Honolulu.

Add to CiteULike CiteULike Add to Connotea Connotea Add to Delicious Delicious Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Variable number of tandem repeats polymorphism in parathyroid hormone-related protein as predictor of peak bone mass in young healthy Finnish males
Gupta et al.
Eur J Endocrinol 2008;158:755-764.
ABSTRACT | FULL TEXT

Osteoporosis therapy: an example of putting evidence-based medicine into clinical practice
Hosking et al.
QJM 2005;98:403-413.
ABSTRACT | FULL TEXT

Internal fixation for displaced fractures of the femoral neck: DOES BONE DENSITY AFFECT CLINICAL OUTCOME?
Heetveld et al.
J Bone Joint Surg Br 2005;87-B:367-373.
ABSTRACT | FULL TEXT

Bone Mineral Density Measurement and Treatment for Osteoporosis in Older Individuals With Fractures: A Gap in Evidence-Based Practice Guideline Implementation
Feldstein et al.
Arch Intern Med 2003;163:2165-2172.
ABSTRACT | FULL TEXT

Gastric and Duodenal Safety of Daily Alendronate
Donahue et al.
Arch Intern Med 2002;162:936-942.
ABSTRACT | FULL TEXT

The rising number of underfoot accidents after the menopause causes both fractures and non-fracture injuries
Davies et al.
QJM 2001;94:699-707.
ABSTRACT | FULL TEXT

Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women
Tonino et al.
J. Clin. Endocrinol. Metab. 2000;85:3109-3115.
ABSTRACT | FULL TEXT

Declining Bone Mass in Men With Chronic Pulmonary Disease* : Contribution of Glucocorticoid Treatment, Body Mass Index, and Gonadal Function
Iqbal et al.
Chest 1999;116:1616-1624.
ABSTRACT | FULL TEXT

Should we look for osteoporosis in patients with rheumatoid arthritis?
LEMS and DIJKMANS
Ann Rheum Dis 1998;57:325-327.
FULL TEXT

| | |